BlackRock
CELG

BlackRock’s Celgene Corp CELG Stock Holding History

BlackRock’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-85,900
Closed -$7.69M – 5197
2018
Q3 		$7.69M Sell
85,900
-900
-1% -$79.5K ﹤0.01% 3357
2018
Q2 		$6.89M Buy
+86,800
New +$7.21M ﹤0.01% 3412

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

BlackRock's CELG Position: Q4 2019 in Review

BlackRock sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 51,897,968 shares — an estimated $5.15B sold.

BlackRock first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $8.09B in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • BlackRock reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • BlackRock sold 51,897,968 Celgene Corp shares in Q4 2019, an estimated $5.15B.
  • BlackRock first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • BlackRock's Celgene Corp position peaked at $8.09B in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on BlackRock's 13F filing for Q4 2019, filed 13 Feb 2020.